ITRM vs OGN · rev $390.0K vs P/E 3.4, rev $6.40B
Iterum Therapeutics PLC (ITRM) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ITRM currently screens at market cap $38.6M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ITRM and OGN stock pages for the full models.
Not investment advice.